1 / 12

Global Corporate Venturing: Healthcare Innovation

Global Corporate Venturing: Healthcare Innovation. Penetration of CVC by Industry . Source: BCG, October 2012, analysing Global Corporate Venturing’s data. New health funds and commitments. GSK’s $50m bioelectronic fund and LP commitment to Kurma Biofund II Stanford- StartX

tacy
Download Presentation

Global Corporate Venturing: Healthcare Innovation

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Global Corporate Venturing: Healthcare Innovation

  2. Penetration of CVC by Industry Source: BCG, October 2012, analysing Global Corporate Venturing’s data

  3. New health funds and commitments • GSK’s $50m bioelectronic fund and LP commitment to KurmaBiofund II • Stanford-StartX • Cipla incubator • BI joins Rockspring • Amgen and Novartis partner with Atlas • Bayer and Roche to QB3 • MS Ventures doubles to €100m • Quintiles’ NovaQuest Source: Sample selected www.GlobalCorporatVenturing.com in 2013

  4. Q2 Fundraising and Trends Source: Global Corporate Venturing * expansion of existing fund

  5. Healthcare CVC’s narcissism Source: BCG, October 2012, analysing Global Corporate Venturing’s 1,300 deals

  6. Source: Global Corporate Venturing

  7. 2011-13 Deal Activity Source: Global Corporate Venturing

  8. Q2 2013 activity Source: Global Corporate Venturing

  9. Q2 Deal Activity • 246 investments worth $5bn • 40 exits – IPOs picking up by number • M&A from portfolio companies up by a third • Series A leads by number of deals • IT most active, healthcare rebounds, • Asia and Europe increasing but US leads

  10. “A global, multimedia publishing group dedicated to serving the intermediaries directing funding to entrepreneurs in the innovation economy.” Contact: James Mawson, founder and editor-in-chief Jmawson@globalcorporateventuring.com +1 650 906 1356 (US main) or +44 (0) 7971655590 (UK)

More Related